A pharmaceutical composition and methods of producing and application of the composition for treating myocardial infarction of a subject are disclosed. The pharmaceutical composition comprises a therapeutically effective amount of at least one synthesized compound selected from the group consisting of SEC, SPC, SBC, SPEC, SAC, SAMC, and SPRC, and a pharmaceutically acceptable carrier.
揭示了一种用于治疗受试者心肌梗死的药物组合物及其制备和应用方法。该药物组合物包括从
SEC、
SPC、SBC、
SPEC、
SAC、S
AMC和
SPRC等化合物组合中选择的至少一种合成化合物的治疗有效量,以及一种药用可接受的载体。